Immune checkpoint inhibitor‐related molecular markers predict prognosis in extrahepatic cholangiocarcinoma

BACKGROUND: Therapeutic approaches for extrahepatic cholangiocarcinoma (EHCC) are limited, due to insufficient understanding to biomarkers related to prognosis and drug response. Here, we comprehensively assess the molecular characterization of EHCC with clinical implications. METHODS: Whole‐exome s...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Bao, Wang, Yuxin, Zhang, Baoluhe, Xu, Haifeng, Lu, Xin, Sang, Xinting, Wang, Wenze, Mao, Yilei, Chen, Pengxiao, Wang, Shun, Qian, Zhirong, Wang, Yingyi, Du, Shunda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652350/
https://www.ncbi.nlm.nih.gov/pubmed/37814942
http://dx.doi.org/10.1002/cam4.6441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652350/
https://www.ncbi.nlm.nih.gov/pubmed/37814942
http://dx.doi.org/10.1002/cam4.6441

Ejemplares similares